Rheumatology Research Review, Issue 74

In this issue:

Chondroitin sulphate vs celecoxib in knee OA
TNF inhibitor + csDMARD comedication: no benefit in SpA
GI tract perforation in RA treated with tofacitinib or a biologic
MRI-detected inflammation and erosions in the general population
Romosozumab promising in postmenopausal osteoporosis
Cardiovascular safety of celecoxib
Dysbiosis triggers arthritis development
Clinical data support EULAR T2T DAS thresholds
Certolizumab pegol vs adalimumab show similar disease activity
Knee OA pain is not influenced by the weather

Please login below to download this issue (PDF)

Subscribe